Key Takeaways
- Sharp quarter-on-quarter recovery: Revenue reached ₹103 crores, EBITDA margin ~15%, and PAT ₹5.8 crores, substantially better than both the previous quarter and the same quarter last year, driven by volume growth and Boron business improvement.
- Export weakness is structural, not cyclical: Overseas sales, particularly agrochemicals into Europe, have collapsed not due to competition but because the market itself has disappeared; management sees no recovery in sight and expects the pain to continue.
- Domestic demand is the engine: Broad-based domestic strength across pigments, fertilizers, paints, and polymers, plus volume and price growth in both commodity and specialty segments, offset the export drag.
- New products are in the pipeline, not yet in the P&L: Two significant products launched this year targeting automotive and multi-industry applications, but they have not yet made a material bottom-line impact; management is investing in process development but not rushing CAPEX.
- What to watch next quarter: Whether the domestic demand uptick proves sustainable beyond a couple of quarters, any sign of European agrochemical stabilization, and progress on customer approvals for the new automotive product.
Top-Line Recovery & Volume Drivers
- Volume-led rebound: Most of the quarter's increase came from higher volumes and improvement in the Boron business, with domestic performance strong on both commodity and specialty sides.
- Boron business turnaround: Debottlenecking has released more product for sale into an improved market; the company is developing downstream Boron products to reduce dependence on commodity-grade material, with significant scope still to grow.
- Broad domestic strength: Pigments, fertilizer volumes, paints, and polymers all picked up, performing much better than in several past quarters.
- Domestic agrochemical traction: Some traction visible in the domestic agrochemical sector, even as international agrochemicals remain a real problem.
- Revenue headroom: With the current asset base, the company can reach around ₹500 crores in revenue, though this depends on selling prices, raw material costs, and ocean freight.
Goculdas: "Our hope is that this demand increase is sustainable and it's coming from a systemic increase in end product requirement, not just some short term changes in stocks and all that, which is yet to be seen. So let's watch for a couple of quarters and see what happens."
Export Weakness & the Europe Problem
- Exports are the drag: Overseas business has not performed well; the slowdown in Europe has drastically affected export sales, and management does not know when this will recover.
- Agrochemicals hit hardest: The export loss is concentrated in agrochemicals, and it is not a competitive loss: the market itself has gone. Even large multinational companies are not showing good international numbers.
- Europe's structural decline: Management sees systemic issues in Europe: high energy costs, low skilled manpower availability, low investment appetite, inflation worries, and strict green laws. European buyers continue sourcing lower-cost products from China.
- Geographic shift underway: Exports have gradually increased from 20% to 22% of sales, with the US and Latin America helping to offset the European decline. Europe is not zero but is in decline as manufacturing shifts away.
- No take-or-pay protection: Customer contracts carry no long-term take-or-pay clauses; customers take product only if they need it, and the company cannot enforce offtake. Losses have been due to products disappearing from the market, not competitive displacement.
Goculdas: "So, these are systemic issues and once it gets into a recession type of situation, the outflow, the whole attitude is negative, and they are more worried about the future than optimistic about the future."
New Product Development & End-Market Expansion
- Two significant launches this year: One product serves a wide range of industries, the other targets automotive applications; both are for the domestic market and management believes they will make a difference if they achieve desired scale.
- Automotive product in approval cycle: The automotive product has been launched and is under multiple customer approvals; some customers have approved and are at commercial stage, while others remain at the trial stage.
- Not yet bottom-line material: New products have not yet made a significant impact on the bottom line; management hopes market development will change that but declined to discuss actual performance until it materializes.
- New end markets, not new sectors: The new products are not entering entirely new sectors for the company but represent new end markets within its existing chemistry capabilities.
- Process development investment continues: The company continues to invest in process development for selected products expected to be globally competitive, bringing them to market gradually.
Margins, Capacity & Capital Allocation
- Specialty capacity underutilized: Specialty chemicals plants are currently operating at lower capacity utilization; once those plants run at higher rates, EBITDA margin will increase.
- No major CAPEX planned: Management has no significant investment plans currently; assets are on the ground and capacities exist in multi-purpose facilities. One good quarter is not enough to justify an investment decision.
- Multi-purpose flexibility as a hedge: The company has invested in multi-purpose facilities that provide flexibility to switch between products, reducing the risk of stranded assets if a single product's market deteriorates.
- Debt repayment trajectory: If cash flow improves, the company can repay more than ₹2 crores per month; term debt is expected to be extinguished in about two years at the current run rate, though working capital debt may continue.
- Shareholder returns on the horizon: Dividend or buyback will be on the table for the Board to consider given reducing leverage.
Goculdas: "One good quarter is not enough to make an investment decision and so we look at it based on the development in our new product for the existing products, I believe we have sufficient..."
Sulfuric Acid Plant Business
- Niche engineering capability: The company has historically built over 50 sulfuric acid plants for customers in India, the Middle East, and Africa; it is the only technology supplier in the world that also operates its own plants.
- Current project pipeline: Working with GSFC for a 600 TPD plant, Mangalore Chemicals and Fertilizers for a 300-350 TPD plant, and others in the pipeline.
- Not a strategic pivot: Management was clear that DMCC will remain a manufacturing company and will not become an engineering company; the sulfuric acid plant business is not very large currently but the engineering capability is retained.
- Opportunistic evaluation: The company will evaluate opportunities in this area given its team, skills, and reputation, but no major shift in business mix is implied.
Customer & Competitive Dynamics
- Sticky customer relationships: Once DMCC is qualified and inside a customer, it does not get dislodged easily; management's experience is that competitive displacement is rare.
- Export losses are market-driven, not competitive: The company has not lost export business to competitors; the products themselves have disappeared from the market as end-demand in Europe evaporated.
- No long-term contracts: Customer relationships operate without take-or-pay agreements; customers take product when they need it, and the company cannot enforce offtake, making demand forecasting inherently uncertain.
- Approval timelines vary widely: When asked about the timeline from prospect to revenue conversion for multi-purpose and development molecules, management declined to give a general timeline, noting that approval times vary significantly by industry.
Goculdas: "We find that and in my experience it's been that, that we don't get dislodged easily once we are in a particular customer."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue potential | ~₹500 crores achievable with current asset base | No date; depends on pricing and input costs |
| Term debt extinguishment | Repay term debt in full at current run rate | ~2 years; may extend if new projects undertaken |
| Margin improvement | EBITDA margin to increase as specialty plants reach higher utilization | When capacity utilization rises |
| New product impact | Two significant products launched; management believes they will make a difference if they achieve desired scale | No timeline; under customer approval process |
| Boron downstream growth | Significant scope to grow Boron business via downstream products; debottlenecking possible | To be discussed over next couple of calls |
| Shareholder returns | Dividend or buyback on the table for Board consideration | As leverage reduces |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Revenue | ₹103 cr, substantially better than previous quarter and Q2 FY24 |
| EBITDA margin | ~15%, improved on higher volumes and Boron business recovery |
| Profit before tax | ₹8.5 cr |
| Profit after tax | ₹5.8 cr |
| Boron business annualized revenue | ₹100–125 cr, close to this run-rate |
| Boron quarterly revenue | ~₹30 cr (per an analyst's math, management confirmed close to that) |
| Bulk chemicals capacity utilization | >90% |
| Specialty chemicals capacity utilization | 50% to 80–85%, varies by plant |
| Revenue potential with current asset base | ~₹500 cr, based on current pricing |
| Exports as a share of revenue | 20–22%, gradually increased; Europe now a small portion of this |
| Debt repayment rate | ~₹2 cr per month over the past year |
| Term debt extinguishment timeline | ~2 years at current run rate |
| Employee attrition | <5% |